Jincan Chen
State Key Laboratory Of Structural Chemistry
Fuzhou, 350108, China
Fuzhou, 350108, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Progress on carboxyl-substituted phthalocyanine photosen-sitizers and their drug delivery systems for photodynamic therapy
Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
Published: July 02, 2025
Polypyridyl biguanide ruthenium complex induces photodynamic membrane damage, ferroptosis-like bacterial death, and "bubbling cell death".
Journal: Journal of inorganic biochemistry
Published: June 26, 2025
Fibrin-targeted photosensitizer aggregates significantly enhance the delivery of chemotherapeutic drugs to tumor vasculature.
Journal: Biomaterials advances
Published: April 23, 2025
Transient intracellular expression of PD-L1 and VEGFR2 bispecific nanobody in cancer cells inspires long-term T cell activation and infiltration to combat tumor and inhibit cancer metastasis.
Journal: Molecular cancer
Published: November 04, 2024
Mitochondria-targeted cyclometalated iridium (III) complexes: Dual induction of A549 cells apoptosis and autophagy.
Journal: Journal of inorganic biochemistry
Published: August 11, 2023
Monomer and Oligomer Transition of Zinc Phthalocyanine Is Key for Photobleaching in Photodynamic Therapy.
Journal: Molecules (Basel, Switzerland)
Published: May 06, 2023
Ruthenium(II) complexes as mitochondrial inhibitors of topoisomerase induced A549 cell apoptosis.
Journal: Journal of inorganic biochemistry
Published: March 21, 2023
A Serum-Stable supramolecular drug carrier for chemotherapeutics fabricated by a Peptide-Photosensitizer conjugate.
Journal: Journal of colloid and interface science
Published: January 31, 2023
A multi-functional nano-system combining PI3K-110α/β inhibitor overcomes P-glycoprotein mediated MDR and improves anti-cancer efficiency.
Journal: Cancer letters
Published: January 05, 2023
An HPK1 inhibitor enhanced the tumour response to anti-PD-1 immunotherapy in non-Hodgkin's lymphoma.
An HPK1 inhibitor enhanced the tumour response to anti-PD-1 immunotherapy in non-Hodgkin's lymphoma.
Journal: Clinical and experimental medicine
Published: November 15, 2022
Functionalized zinc oxide microparticles for improving the antimicrobial effects of skin-care products and wound-care medicines.
Journal: Biomaterials advances
Published: November 29, 2021
Suppression of cancer proliferation and metastasis by a versatile nanomedicine integrating photodynamic therapy, photothermal therapy, and enzyme inhibition.
Journal: Acta biomaterialia
Published: January 21, 2020
Last Updated: 09/26/2026